Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
SK Biopharmaceuticals.
(326030.KQ) Q1 2026
Earnings
326030.KQ
Feb 6
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
236
727
1,219
1,711
Details
Expected EPS
438
Actual EPS
1,711
Surprise EPS
1,273
Surprise Percent
+290.53%
Description
SK Biopharmaceuticals. (326030.KQ) has reported earnings of 1,711 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login